HC Wainwright & Co. Reiterates Buy on Ekso Bionics Holdings, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Ekso Bionics Holdings (NASDAQ:EKSO) and maintained a $10 price target.
July 30, 2024 | 11:09 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Ekso Bionics Holdings and maintained a $10 price target, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $10 price target by HC Wainwright & Co. suggests strong confidence in Ekso Bionics Holdings' future performance. This positive analyst rating is likely to boost investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100